Trials / Completed
CompletedNCT00363740
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
Clinical Evaluation of GW685698 for Seasonal Allergic Rhinitis -A Placebo-controlled Study to Determine the Non-inferiority of GW685698 Over Fluticasone Propionate Using a Double-blind Manner-
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray and commonly used drug in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Typical symptoms are sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW685698X Aqueous Nasal Spray |
Timeline
- Start date
- 2005-02-19
- Primary completion
- 2005-04-01
- Completion
- 2005-04-13
- First posted
- 2006-08-15
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT00363740. Inclusion in this directory is not an endorsement.